Blood immune profiling of AD patients and healthy individuals has revealed a higher percentage of activated HLA-DR+ CD8+ T cells and augmented release of pro-inflammatory cytokines [142, 275], suggesting that circulating cytotoxic T cells are activated in the blood of AD patients. The gene discussed is CD8A; the disease is Alzheimer disease.